The Occurrence of Single Nucleotide Polymorphism Among Women Who Experienced Obstetric Anal Sphincter Injury

Sponsor
HaEmek Medical Center, Israel (Other)
Overall Status
Recruiting
CT.gov ID
NCT04047433
Collaborator
(none)
150
1
2
29.8
5

Study Details

Study Description

Brief Summary

Single-nucleotide polymorphisms (SNP's) in connective tissue components are associated with increased risk of pelvic organ prolapse (POP). The investigators expect to find a difference in SNP's frequency between women who had Obstetric anal sphincter injuries (OASIS) and in the healthy population. The fact that pelvic organ prolapse (POP) and OASIS occurs in the same anatomic region and the well-known association between few SNP's and the risk for POP, suggests for a common pathophysiology.

Condition or Disease Intervention/Treatment Phase
  • Genetic: screening for single nucleotide polymorphism
  • Genetic: whole exome sequencing
N/A

Detailed Description

The perineum consists of skin, muscles and connective tissue. A connective tissue disorder related to POP has been reported in biochemical and molecular studies. OASIS are considered a severe complication of vaginal delivery that may lead to a great deal of morbidity. Familial history is known as a risk factor for OASIS. Currently, there is no established genetic link between connective tissue components and OASIS. Therefore, the investigators assume that studying the genetic predisposition factors of women who experience OASIS, might generate a stronger tool to predict severe occurrence of vaginal laceration. It may also help to consult women before vaginal delivery about the risk of OASIS.

The aim of this study is to find an association between genetic variation and increased risk for OASIS.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
two arms - with external anal sphincter injury without injury both will go through genetic screening test the arm with the external anal sphincter injury will also be tested for advanced genetic testingtwo arms - with external anal sphincter injury without injury both will go through genetic screening test the arm with the external anal sphincter injury will also be tested for advanced genetic testing
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
The Occurrence of Single Nucleotide Polymorphism Among Women Who Experienced Obstetric Anal Sphincter Injury
Actual Study Start Date :
Sep 4, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: women with external anal sphincter injury

The study cohort will be composed of women undergoing vaginal delivery and diagnosed with external anal sphincter injury after a vaginal delivery.

Genetic: screening for single nucleotide polymorphism
samples will be tested for a set of single nucleotide polymorphism

Genetic: whole exome sequencing
samples will be tested for identifying specific genetic mutation

Experimental: women without external anal sphincter injury

The control group will be women who had a vaginal delivery without any clinically apparent perineal laceration

Genetic: screening for single nucleotide polymorphism
samples will be tested for a set of single nucleotide polymorphism

Outcome Measures

Primary Outcome Measures

  1. difference in the frequency of of Single-nucleotide polymorphisms [through study completion, an average of 2 years]

    difference in the relative frequency of Single-nucleotide polymorphisms between women with external anal sphincter injury that occurs during vaginal delivery and those without it.

Secondary Outcome Measures

  1. genetic mutation [through study completion, an average of 2 years]

    specific genetic mutation among women with external anal sphincter injury that occurs during vaginal delivery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women with severe external anal sphincter injury during first vaginal delivery

  • Healthy women undergoing vaginal delivery without any clinically apparent perineal laceration

Exclusion Criteria:
  • Women with known metabolic or connective-tissue disorder (e.g., Ehlers-Danlos syndrome).

  • Women with known neurologic disorder

  • Women undergoing episiotomy cut or assisted delivery (e.g., vacuum or forceps delivery)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Haemek Medical Center Afula Israel

Sponsors and Collaborators

  • HaEmek Medical Center, Israel

Investigators

  • Principal Investigator: Eyal Rom, MD, haemek medical center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eyal Rom, MD, Principal Investigator, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT04047433
Other Study ID Numbers:
  • 0091-18-EMC
First Posted:
Aug 6, 2019
Last Update Posted:
Jan 25, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 25, 2022